Blood filter shows promise for autoimmune patients
NCT ID NCT04078698
First seen Jun 26, 2026 · Last updated Jun 26, 2026
Summary
This study looked at a device called GLOBAFFIN that filters antibodies from the blood to help people with autoimmune diseases. It involved 34 adults and measured how much harmful antibodies were removed and if patients felt better. The goal was to see if the device is safe and works well in everyday medical practice.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
Active substance
GLOBAFFIN immunoadsorber (a device that filters antibodies from the blood)
What this could lead to
If successful, this could confirm that the GLOBAFFIN device is a safe and effective way to manage autoimmune diseases by removing harmful antibodies.
What could go wrong
This is a small, completed observational study with only 34 patients, so results may not apply to everyone. It does not compare the device to other treatments, so its true benefit is uncertain.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for AUTOIMMUNE DISEASES are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Diakonissenkrankenhaus Flensburg
Flensburg, 24939, Germany
-
Städtisches Klinikum Braunschweig
Braunschweig, Lower Saxony, 38126, Germany
-
University of Ulm - Department of Neurology
Ulm, 89081, Germany